Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 28 (RPS2P28) is a processed pseudogene of the ribosomal protein S2 gene. Pseudogenes like RPS2P28 are duplicated gene sequences that have lost their ability to code for functional proteins. They are prevalent throughout the human genome, especially among ribosomal protein gene families. RPS2P28 shares homology with the functional RPS2 gene, which encodes a ribosomal protein component of the 40S subunit involved in protein synthesis, but RPS2P28 itself is non-functional due to mutations or lack of regulatory elements required for expression. Summary: RPS2P28 is a processed pseudogene, not a drug or therapeutic target. It should not be treated as a functional protein, receptor, or typical drug discovery target.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 28 (RPS2P28).